Literature DB >> 22928632

Comparison of quantitative estimation of intracerebral hemorrhage and infarct volumes after thromboembolism in an embolic stroke model.

Nina Eriksen1, Rune S Rasmussen, Karsten Overgaard, Flemming F Johansen, Bente Pakkenberg.   

Abstract

BACKGROUND: Strokes have both ischemic and hemorrhagic components, but most studies of experimental stroke only address the ischemic component. This is likely because investigations of hemorrhagic transformation are hindered by the lack of methods based on unbiased principles for volume estimation. AIMS: We evaluated different methods for estimating the volume of infarcts, hemorrhages, after embolic middle cerebral artery occlusion with or without thrombolysis.
METHODS: An experimental thromboembolytic rat model was used in this study. The rats underwent surgery and were placed in two groups. Group 1 was treated with saline, and group 2 was treated with 20 mg/kg recombinant tissue plasminogen activator to promote intracerebral hemorrhages. Stereology, semiautomated computer estimation, and manual erythrocyte counting were used to test the precision and efficiency of determining the size of the infarct and intracerebral hemorrhage.
RESULTS: No differences were observed in the infarct volume or amount of bleeding when comparing the three methods of volume estimation. Although semiautomated computer estimation and manual erythrocyte counting provided similar results as the stereological measurements, the stereological method was the most efficient and advantageous.
CONCLUSIONS: We found that stereology was the superior method for quantification of hemorrhagic volume, especially for rodent petechial bleeding, which is otherwise difficult to measure. Our results suggest the possibility of measuring both the ischemic and the hemorrhagic components of stroke, two parameters that may be differentially regulated when therapeutic regimens are tested.
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.

Entities:  

Keywords:  acute stroke therapy; brain; cerebral hemorrhage; cerebral infarction; stroke; tPA

Mesh:

Substances:

Year:  2012        PMID: 22928632     DOI: 10.1111/j.1747-4949.2012.00870.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  2 in total

1.  Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats.

Authors:  Xiang Fan; Yinghua Jiang; Zhanyang Yu; Qi Liu; Shuzhen Guo; Xiaochuan Sun; Klaus van Leyen; MingMing Ning; Xiumei Gao; Eng H Lo; Xiaoying Wang
Journal:  Transl Stroke Res       Date:  2017-06-04       Impact factor: 6.829

2.  Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke.

Authors:  Andreas Reimann; Zhongmin Li; Silvia Goebel; Julia Fassbender; Hans-Peter Holthoff; Meinrad Gawaz; Götz Münch; Martin Ungerer
Journal:  Heart Int       Date:  2016-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.